Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet
2023-10-23 16:50
Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
You Might Like...
These Stocks Are Moving the Most Today: Microsoft, GM, Zoom Video, Nvidia, and More
New open world video game PAW Patrol World coming in September
The Best Graphic Design Software for 2023
'It's robbery': Salvadorans slow to adopt Bitcoin
Everything Amazon Announced at Its Fall Event: Echo, Fire TV, Ring, and More
US author Cormac McCarthy dies aged 89
New Warzone Map Urzikstan Revealed for Modern Warfare 3
Who is Ray? Kai Cenat talks to his friend about his crush: 'My soulmate is out here'